| PCS-2023 > 3 > 3E > 3E0 > 3E0P |
3E0 | Physiological Systems and Anatomical Regions, Introduction | |
Info: | Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products | |
3E0P | Introduction, Female Reproductive | |
3E0P0 | Open | |
3E0P05 | Adhesion Barrier | |
3E0P05Z | Introduction of Adhesion Barrier into Female Reproductive, Open Approach | |
3E0P3 | Percutaneous | |
3E0P30 | Antineoplastic | |
3E0P304 | Introduction of Liquid Brachytherapy Radioisotope into Female Reproductive, Percutaneous Approach | |
3E0P305 | Introduction of Other Antineoplastic into Female Reproductive, Percutaneous Approach | |
3E0P30M | Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Percutaneous Approach | |
3E0P32 | Anti-infective | |
3E0P328 | Introduction of Oxazolidinones into Female Reproductive, Percutaneous Approach | |
3E0P329 | Introduction of Other Anti-infective into Female Reproductive, Percutaneous Approach | |
3E0P33 | Anti-inflammatory | |
3E0P33Z | Introduction of Anti-inflammatory into Female Reproductive, Percutaneous Approach | |
3E0P35 | Adhesion Barrier | |
3E0P35Z | Introduction of Adhesion Barrier into Female Reproductive, Percutaneous Approach | |
3E0P36 | Nutritional Substance | |
3E0P36Z | Introduction of Nutritional Substance into Female Reproductive, Percutaneous Approach | |
3E0P37 | Electrolytic and Water Balance Substance | |
3E0P37Z | Introduction of Electrolytic and Water Balance Substance into Female Reproductive, Percutaneous Approach | |
3E0P3B | Anesthetic Agent | |
3E0P3BZ | Introduction of Anesthetic Agent into Female Reproductive, Percutaneous Approach | |
3E0P3H | Radioactive Substance | |
3E0P3HZ | Introduction of Radioactive Substance into Female Reproductive, Percutaneous Approach | |
3E0P3K | Other Diagnostic Substance | |
3E0P3KZ | Introduction of Other Diagnostic Substance into Female Reproductive, Percutaneous Approach | |
3E0P3L | Sperm | |
3E0P3LZ | Introduction of Sperm into Female Reproductive, Percutaneous Approach | |
3E0P3N | Analgesics, Hypnotics, Sedatives | |
3E0P3NZ | Introduction of Analgesics, Hypnotics, Sedatives into Female Reproductive, Percutaneous Approach | |
3E0P3T | Destructive Agent | |
3E0P3TZ | Introduction of Destructive Agent into Female Reproductive, Percutaneous Approach | |
3E0P3V | Hormone | |
3E0P3VZ | Introduction of Hormone into Female Reproductive, Percutaneous Approach | |
3E0P3G | Other Therapeutic Substance | |
3E0P3GC | Introduction of Other Therapeutic Substance into Female Reproductive, Percutaneous Approach | |
3E0P3Q | Fertilized Ovum | |
3E0P3Q0 | Introduction of Autologous Fertilized Ovum into Female Reproductive, Percutaneous Approach | |
3E0P3Q1 | Introduction of Nonautologous Fertilized Ovum into Female Reproductive, Percutaneous Approach | |
3E0P3S | Gas | |
3E0P3SF | Introduction of Other Gas into Female Reproductive, Percutaneous Approach | |
3E0P4 | Percutaneous Endoscopic | |
3E0P45 | Adhesion Barrier | |
3E0P45Z | Introduction of Adhesion Barrier into Female Reproductive, Percutaneous Endoscopic Approach | |
3E0P4G | Other Therapeutic Substance | |
3E0P4GC | Introduction of Other Therapeutic Substance into Female Reproductive, Percutaneous Endoscopic Approach | |
3E0P7 | Via Natural or Artificial Opening | |
3E0P70 | Antineoplastic | |
3E0P704 | Introduction of Liquid Brachytherapy Radioisotope into Female Reproductive, Via Natural or Artificial Opening | |
3E0P705 | Introduction of Other Antineoplastic into Female Reproductive, Via Natural or Artificial Opening | |
3E0P70M | Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Via Natural or Artificial Opening | |
3E0P72 | Anti-infective | |
3E0P728 | Introduction of Oxazolidinones into Female Reproductive, Via Natural or Artificial Opening | |
3E0P729 | Introduction of Other Anti-infective into Female Reproductive, Via Natural or Artificial Opening | |
3E0P73 | Anti-inflammatory | |
3E0P73Z | Introduction of Anti-inflammatory into Female Reproductive, Via Natural or Artificial Opening | |
3E0P76 | Nutritional Substance | |
3E0P76Z | Introduction of Nutritional Substance into Female Reproductive, Via Natural or Artificial Opening | |
3E0P77 | Electrolytic and Water Balance Substance | |
3E0P77Z | Introduction of Electrolytic and Water Balance Substance into Female Reproductive, Via Natural or Artificial Opening | |
3E0P7B | Anesthetic Agent | |
3E0P7BZ | Introduction of Anesthetic Agent into Female Reproductive, Via Natural or Artificial Opening | |
3E0P7H | Radioactive Substance | |
3E0P7HZ | Introduction of Radioactive Substance into Female Reproductive, Via Natural or Artificial Opening | |
3E0P7K | Other Diagnostic Substance | |
3E0P7KZ | Introduction of Other Diagnostic Substance into Female Reproductive, Via Natural or Artificial Opening | |
3E0P7L | Sperm | |
3E0P7LZ | Introduction of Sperm into Female Reproductive, Via Natural or Artificial Opening | |
3E0P7N | Analgesics, Hypnotics, Sedatives | |
3E0P7NZ | Introduction of Analgesics, Hypnotics, Sedatives into Female Reproductive, Via Natural or Artificial Opening | |
3E0P7T | Destructive Agent | |
3E0P7TZ | Introduction of Destructive Agent into Female Reproductive, Via Natural or Artificial Opening | |
3E0P7V | Hormone | |
3E0P7VZ | Introduction of Hormone into Female Reproductive, Via Natural or Artificial Opening | |
3E0P7G | Other Therapeutic Substance | |
3E0P7GC | Introduction of Other Therapeutic Substance into Female Reproductive, Via Natural or Artificial Opening | |
3E0P7Q | Fertilized Ovum | |
3E0P7Q0 | Introduction of Autologous Fertilized Ovum into Female Reproductive, Via Natural or Artificial Opening | |
3E0P7Q1 | Introduction of Nonautologous Fertilized Ovum into Female Reproductive, Via Natural or Artificial Opening | |
3E0P7S | Gas | |
3E0P7SF | Introduction of Other Gas into Female Reproductive, Via Natural or Artificial Opening | |
3E0P8 | Via Natural or Artificial Opening Endoscopic | |
3E0P80 | Antineoplastic | |
3E0P804 | Introduction of Liquid Brachytherapy Radioisotope into Female Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0P805 | Introduction of Other Antineoplastic into Female Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0P80M | Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0P82 | Anti-infective | |
3E0P828 | Introduction of Oxazolidinones into Female Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0P829 | Introduction of Other Anti-infective into Female Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0P83 | Anti-inflammatory | |
3E0P83Z | Introduction of Anti-inflammatory into Female Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0P86 | Nutritional Substance | |
3E0P86Z | Introduction of Nutritional Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0P87 | Electrolytic and Water Balance Substance | |
3E0P87Z | Introduction of Electrolytic and Water Balance Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0P8B | Anesthetic Agent | |
3E0P8BZ | Introduction of Anesthetic Agent into Female Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0P8H | Radioactive Substance | |
3E0P8HZ | Introduction of Radioactive Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0P8K | Other Diagnostic Substance | |
3E0P8KZ | Introduction of Other Diagnostic Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0P8N | Analgesics, Hypnotics, Sedatives | |
3E0P8NZ | Introduction of Analgesics, Hypnotics, Sedatives into Female Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0P8T | Destructive Agent | |
3E0P8TZ | Introduction of Destructive Agent into Female Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0P8G | Other Therapeutic Substance | |
3E0P8GC | Introduction of Other Therapeutic Substance into Female Reproductive, Via Natural or Artificial Opening Endoscopic | |
3E0P8S | Gas | |
3E0P8SF | Introduction of Other Gas into Female Reproductive, Via Natural or Artificial Opening Endoscopic | |
|
ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine |